Yasuo Urata
Founder bei ONCOLYS BIOPHARMA INC.
Vermögen: 3 Mio $ am 31.03.2024
Profil
Yasuo Urata is the founder of Oncolys BioPharma, Inc. which was founded in 2004.
He is currently the Chairman of Oncolys USA, Inc. since 2016.
Mr. Urata was an Outside Director at Tacere Therapeutics, Inc. in 2011 and an Independent Director at WONIK CUBE Corp.
He worked as a Principal at Japan Tobacco, Inc. from 1994 to 2004 and at Ono Pharmaceutical Co., Ltd.
Mr. Urata graduated from Kyoto Pharmaceutical University with a graduate degree in 1983 and from Tokai High School with an undergraduate degree in 1974.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
ONCOLYS BIOPHARMA, INC.
2,45% | 31.12.2022 | 496 900 ( 2,45% ) | 3 Mio $ | 31.03.2024 |
Aktive Positionen von Yasuo Urata
| Unternehmen | Position | Beginn |
|---|---|---|
| ONCOLYS BIOPHARMA INC. | Founder | 18.03.2004 |
| Oncolys USA, Inc. | Chairman | 01.08.2016 |
Ehemalige bekannte Positionen von Yasuo Urata
| Unternehmen | Position | Ende |
|---|---|---|
| JAPAN TOBACCO, INC. | Corporate Officer/Principal | - |
| ONO PHARMACEUTICAL CO., LTD. | Corporate Officer/Principal | - |
| WONIK CUBE CORP. | Director/Board Member | - |
Tacere Therapeutics, Inc.
 Tacere Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Tacere Therapeutics, Inc. provides treatment of infectious diseases. It develops novel therapeutics for the treatment of serious infectious diseases such as Hepatitis C (HCV). The company was founded by Sara M. Hall, Amit J. Kumar, John James Monahan, and Michael J. Catelani in 2006 and is headquartered in San Jose, CA. | Director/Board Member | - |
Ausbildung von Yasuo Urata
| Kyoto Pharmaceutical University | Graduate Degree |
| Tokai High School | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 4 |
|---|---|
| JAPAN TOBACCO, INC. | Consumer Non-Durables |
| ONO PHARMACEUTICAL CO., LTD. | Health Technology |
| WONIK CUBE CORP. | Distribution Services |
| ONCOLYS BIOPHARMA INC. | Health Technology |
| Private Unternehmen | 2 |
|---|---|
Tacere Therapeutics, Inc.
Tacere Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Tacere Therapeutics, Inc. provides treatment of infectious diseases. It develops novel therapeutics for the treatment of serious infectious diseases such as Hepatitis C (HCV). The company was founded by Sara M. Hall, Amit J. Kumar, John James Monahan, and Michael J. Catelani in 2006 and is headquartered in San Jose, CA. | Health Technology |
| Oncolys USA, Inc. |
